Announcement PDF 1 April 2019 Lisa Banh Senior Listings Adviser, Listings Compliance ASX Compliance Pty Ltd 20 Bridge St SYDNEY NSW 2000 Dear Lisa RESPONSE TO PRICE QUERY I refer to your letter to Invion Limited (“Company”) dated 1 April 2019, and respond to your questions as follows: 1. The Company is not aware of any information concerning it that has not been announced to the market which, if known by some in the market, could be an explanation for recent trading in the securities of the Company. 2. In light of 1. above, not applicable. 3. On 29 February 2019, the Company lodged a Corporate Update and Investor Presentation outlining the clinical strategy for its development of the PhotosoftTM technology and the forward focus of the Company. The presentation was to accompany meetings being undertaken by MD & CEO, Dr Greg Collier during March 2019. On 29 March 2019, NDF Research (“NDF”) published research initiating coverage on the Company. This commissioned research was published to NDF’s subscriber base, to Invion’s website and to Invion’s subscriber base. On 1 April 2019, an email was distributed to subscribers of Hot Copper which linked to a sponsored ‘Corporate Spotlight’. The sponsor of the Corporate Spotlight, Vantage Point Partners, provided a description of Invion, a summary of key points of the NDF report and a link to the research report. Aside from this information, the Company does not have any other explanation for the recent trading of its securities. 4. The Company is in compliance with the Listing Rules and, in particular, Listing Rule 3.1. 5. The Company confirms that its responses provided above have been authorised and approved in accordance with its published continuous disclosure policy and by an officer of the Company with delegated authority from the Board to respond to ASX on disclosure matters. Yours sincerely Melanie Farris Company Secretary Invion Limited ABN 76 094 730 417 722 High Street, East Kew, VIC 3102 Australia P: +61 3 9081 6005 W: www.inviongroup.com 1 April 2019 Ms Melanie Farris Company Secretary Invion Limited Unit 2, 120 Bluestone Circuit Seventeen Mile Rocks QLD 4073 By email: Dear Ms Farris Invion Limited (‘IVX’): Price Query We note the change in the price of IVX’s securities from a low of $1.3 cents to a high of $1.8 cents today. We also note the significant increase in the volume of IVX’s securities traded from 29 March 2019 to 1 April 2019. Request for Information In light of this, ASX asks IVX to respond separately to each of the following questions and requests for information: 1. Is IVX aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities? 2. If the answer to question 1 is “yes”. (a) Is IVX relying on Listing Rule 3.1A not to announce that information under Listing Rule 3.1? Please note that the recent trading in IVX’s securities would suggest to ASX that such information may have ceased to be confidential and therefore IVX may no longer be able to rely on Listing Rule 3.1A. Accordingly, if the answer to this question is “yes”, you need to contact us immediately to discuss the situation. (b) Can an announcement be made immediately? Please note, if the answer to this question is “no”, you need to contact us immediately to discuss requesting a trading halt (see below). (c) If an announcement cannot be made immediately, why not and when is it expected that an announcement will be made? 3. If the answer to question 1 is “no”, is there any other explanation that IVX may have for the recent trading in its securities? 4. Please confirm that IVX is complying with the Listing Rules and, in particular, Listing Rule 3.1. 5. Please confirm that IVX’s responses to the questions above have been authorised and approved under its published continuous disclosure policy or otherwise by its board or an officer of IVX with delegated authority from the board to respond to ASX on disclosure matters. When and where to send your response This request is made under Listing Rule 18.7. Your response is required as soon as reasonably possible and, in any event, by no later than 3:00 PM AEST today Monday, 1 April 2019. If we do not have your response by then, ASX will likely suspend trading in IVX’s securities under Listing Rule 17.3. You should note that if the information requested by this letter is information required to be given to ASX under Listing Rule 3.1 and it does not fall within the exceptions mentioned in Listing Rule 3.1A, IVX’s obligation is to disclose the ASX Limited [[Listings]] ASX Customer Service Centre 131 279 | asx.com.au information “immediately”. This may require the information to be disclosed before the deadline set out in the previous paragraph. ASX reserves the right to release a copy of this letter and your response on the ASX Market Announcements Platform under Listing Rule 18.7A. Accordingly, your response should be in a form suitable for release to the market. Your response should be sent to me by e-mail at ListingsComplianceSydney@asx.com.au. It should not be sent directly to the ASX Market Announcements Office. This is to allow me to review your response to confirm that it is in a form appropriate for release to the market, before it is published on the ASX Market Announcements Platform. Listing Rules 3.1 and 3.1A Listing Rule 3.1 requires a listed entity to give ASX immediately any information concerning it that a reasonable person would expect to have a material effect on the price or value of the entity’s securities. Exceptions to this requirement are set out in Listing Rule 3.1A. In responding to this letter, you should have regard to IVX’s obligations under Listing Rules 3.1 and 3.1A and also to Guidance Note 8 Continuous Disclosure: Listing Rules 3.1 – 3.1B. It should be noted that IVX’s obligation to disclose information under Listing Rule 3.1 is not confined to, nor is it necessarily satisfied by, answering the questions set out in this letter. Trading halt If you are unable to respond to this letter by the time specified above, or if the answer to question 1 is “yes” and an announcement cannot be made immediately, you should discuss with us whether it is appropriate to request a trading halt in IVX’s securities under Listing Rule 17.1. If you wish a trading halt, you must tell us:  the reasons for the trading halt;  how long you want the trading halt to last;  the event you expect to happen that will end the trading halt;  that you are not aware of any reason why the trading halt should not be granted; and  any other information necessary to inform the market about the trading halt, or that we ask for. We may require the request for a trading halt to be in writing. The trading halt cannot extend past the commencement of normal trading on the second day after the day on which it is granted. You can find further information about trading halts in Guidance Note 16 Trading Halts & Voluntary Suspensions. Suspension If you are unable to respond to this letter by the time specified above ASX will likely suspend trading in IVX’s securities under Listing Rule 17.3. Enquiries If you have any queries or concerns about any of the above, please contact me immediately. Regards Lisa Banh Senior Adviser, Listings Compliance (Sydney) 2/2 ASX Customer Service Centre 131 279 | asx.com.au